Lil­ly picks a Foghorn tar­get; Min­eralys’ $120M PIPE; Sana's $165M of­fer­ing

Plus, news about Telix, QSAM Bio­sciences, Nicox, and Kowa:

Eli Lil­ly se­lects Foghorn can­di­date for de­vel­op­ment: Foghorn’s stock $FHTX jumped 16% on Thurs­day morn­ing af­ter it said the phar­ma gi­ant se­lect­ed its oral BRM se­lec­tive in­hibitor for clin­i­cal de­vel­op­ment. The com­pa­nies plan to test FHD-909 in pa­tients with BRG1 mu­tat­ed non-small cell lung can­cer as part of a deal inked in 2021 that can pro­vide up to $1.3 bil­lion in mile­stones.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER